4/A//SEC Filing
Mattsson Jan 4/A
Accession 0001209191-23-005337
CIK 0001322505other
Filed
Jan 26, 7:00 PM ET
Accepted
Jan 27, 5:28 PM ET
Size
5.5 KB
Accession
0001209191-23-005337
Insider Transaction Report
Form 4/AAmended
Mattsson Jan
Chief Operating Officer
Transactions
- Award
Common Stock
2023-01-19+55,000→ 109,474 total
Footnotes (2)
- [F1]Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest as to 25% of the shares on January 19, 2024, 6.25% of the shares every three months thereafter beginning on April 19, 2024 and ending on January 19, 2025, and 12.5% of the shares every three months thereafter beginning on April 19, 2025 and ending on January 19, 2026.
- [F2]Represents 35,524 shares of common stock and 73,950 restricted stock units.
Documents
Issuer
ALBIREO PHARMA, INC.
CIK 0001322505
Entity typeother
Related Parties
1- filerCIK 0001687436
Filing Metadata
- Form type
- 4/A
- Filed
- Jan 26, 7:00 PM ET
- Accepted
- Jan 27, 5:28 PM ET
- Size
- 5.5 KB